Revenue | ₹7.59Cr |
Net Profits | ₹2.38Cr |
Net Profit Margins | 31.36% |
Shukra Pharmaceuticals Ltd’s revenue jumped 15.53% since last year same period to ₹7.59Cr in the Q2 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 16.77% jump in its revenue since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit jumped 340.74% since last year same period to ₹2.38Cr in the Q2 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 131.07% jump in its net profits since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit margin jumped 281.51% since last year same period to 31.36% in the Q2 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 97.88% jumped in its net profit margins since last 3-months.
The revenue for Shukra Pharmaceuticals Ltd in the Q2 results 2025 was ₹7.59Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q2 results 2025 was ₹2.38Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q2 results 2025 was 31.36%.
The revenue for Shukra Pharmaceuticals Ltd in the Q2 results 2024 was ₹6.57Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q2 results 2024 was ₹0.54Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q2 results 2024 was 8.22%.